In vivo short-term effects of recombinant human TNF-a on lipolysis, FFA flux, fat oxidation, triglyceride-fatty acid cycling, and glucose kinetics were evaluated with stable isotopic tracers and indirect calorimetry along with monitoring of hemodynamic parameters in fasted dogs. High-dose TNF infusion ( 10 ,gg/kg) caused a fall in mean arterial pressure (P < 0.01), pulmonary arterial pressure (P < 0.001), and cardiac index (CI) (P < 0.05). The rate of appearance of glycerol (Ra glycerol) and the rate of appearance of FFA (Ra FFA) were decreased by 20% (P < 0.05) and by 42% (P < 0.01), respectively. Total fat oxidation fell by 23% (P < 0.05). In contrast, TNF infusion significantly increased glucose production by 13% (P < 0.05) and metabolic clearance rate of glucose by 25% (P < 0.01). However, TNF infusion did not change energy expenditure. Low-dose TNF infusion (3.5 ;tg/kg) caused changes similar in all respects, except magnitude, to the highdose effects. There was a significant correlation between percent change of CI (ACI) and percent change of rate of appearance of palmitate (Ra palmitate; ARa palmitate) (P < 0.0001, r = 0.69), Ra FFA (ARa FFA) (P < 0.0001, r = 0.60), and Ra glycerol (ARa glycerol) (P < 0.0329, r = 0.36). The correlation between ACI and ARa palmitate was greater than the correlation between ACI and ARa glycerol (P = 0.028). We conclude that the acute response to TNF causes a shift towards carbohydrate as an energy substrate in a dose-dependent manner by both decreasing the availability of FFAs and increasing glucose production. (J. Clin. Invest. 1993.91:2437-2445